Author Contact
WorldPress Partners
WorldPress Partners
Company Contact
WorldPress Partners
More Post from the Author

Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System

Published on Mon 3 Feb 2025 2:31:05 UTC

Company Contact Information
Consumers:
866-770-3024
[emailprotected]
Press:
[emailprotected]

MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch. This transdermal system is manufactured by Kindeva Drug Delivery L.P., Northridge, CA and is distributed by Alvogen, Inc. as a private label distributor.

Continue Reading

Image Source: Alvogen, Inc.
Image Source: Alvogen, Inc.
Image Source: Alvogen, Inc.
Image Source: Alvogen, Inc.
Image Source: Alvogen, Inc.
Image Source: Alvogen, Inc.
Image Source: Alvogen, Inc.
Image Source: Alvogen, Inc.
Author Contact
WorldPress Partners
WorldPress Partners
Company Contact
WorldPress Partners
More Post from the Author